Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807]

Affiliations

• ¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
• ² United-Power Pharma Tech Co., Ltd., Beijing, China.
• ³ Department of Pharmacy, Peking University People's Hospital, Beijing, China; Xuzhou Medical University, Xuzhou, China.
• ⁴ Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
• ⁵ Department of Pharmacy, Peking University People's Hospital, Beijing, China.
• ⁶ Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
• ⁷ Aix-Marseille University, 27 bd Jean Moulin, 13385 Marseille Cedex 05, France.
• ⁸ The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
• ⁹ Shenyang Sunshine Pharmaceutical Co., Ltd, Shenyang, China.
• ¹⁰ State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, China; National Engineering Research Center for Protein Drugs, Beijing, China. Electronic address: songhf@nic.bmi.ac.cn.
• ¹¹ Department of Pharmacy, Peking University People's Hospital, Beijing, China. Electronic address: phaseistudy@163.com.